Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Akebia TherapeuticsXBiotechOdonate TherapeuticsAmphastar PharmaceuticalsRevance Therapeutics
SymbolNASDAQ:AKBANASDAQ:XBITNASDAQ:ODTNASDAQ:AMPHNASDAQ:RVNC
Price Information
Current Price$9.19$14.92$31.67$18.81$25.93
52 Week RangeBuyBuyHoldHoldBuy
Analyst Ratings
Consensus RecommendationBuyBuyHoldHoldBuy
Consensus Price Target$13.80$28.00$26.00$24.73$28.71
% Upside from Price Target50.16% upside87.67% upside-17.90% downside31.49% upside10.74% upside
Trade Information
Market Cap$1.04 billion$618.82 million$1.01 billion$899.80 million$1.14 billion
Beta1.710.611.81.211.16
Average Volume1,243,1561,176,84759,246168,572959,854
Sales & Book Value
Annual Revenue$207.74 millionN/AN/A$294.67 million$3.73 million
Price / Sales5.26N/AN/A3.00313.58
CashflowN/AN/AN/A$0.57 per shareN/A
Price / CashN/AN/AN/A32.83N/A
Book Value$5.44 per share$1.16 per share$4.62 per share$7.90 per share$3.94 per share
Price / Book1.69N/AN/A2.386.58
Profitability
Net Income$-143,590,000.00$-21,140,000.00$-88,960,000.00$-5,740,000.00$-142,570,000.00
EPS($2.44)($0.59)($3.64)$0.21($3.94)
Trailing P/E RatioN/AN/AN/A17.91N/A
Forward P/E RatioN/A64.87N/A34.83N/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-75.39%N/AN/A15.77%N/A
Return on Equity (ROE)-32.74%-45.15%-75.22%5.07%-87.59%
Return on Assets (ROA)-20.44%-43.03%-65.31%3.63%-55.63%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.06%N/AN/A0.13%0.18%
Current Ratio1.34%20.24%8.41%3.11%6.46%
Quick Ratio0.82%20.24%8.41%1.84%6.46%
Ownership Information
Institutional Ownership Percentage70.27%12.33%97.55%51.77%99.37%
Insider Ownership Percentage2.66%33.40%59.30%30.80%5.20%
Miscellaneous
Employees324561172,078170
Shares Outstanding118.94 million41.09 million32.08 million46.94 million45.11 million
Next Earnings Date3/24/2020 (Estimated)3/11/2020 (Estimated)2/28/2020 (Estimated)3/10/2020 (Estimated)2/24/2020 (Confirmed)
OptionableOptionableOptionableNot OptionableOptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel